Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms

NCT05162833 is registered in ClinicalTrials.gov with Theranova, L.L.C. as lead sponsor.

NCT NCT05162833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05162833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms
Lead sponsor
Theranova, L.L.C.
Phase
Not applicable
Overall status
Completed
Start date
February 20, 2022
Completion date
December 8, 2023
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder